Significant secondary mitral regurgitation (SMR) is known to be associated with worse prognosis. However, data focusing specifically on moderate SMR a...

Atrial fibrillation (Afib) is a prevalent chronic arrhythmia associated with severe complications, including stroke, heart failure, and increased mort...

There are limited data evaluating the utility of revascularization strategies for patients with chronic kidney disease (CKD). Although it is well established that CKD is an important risk factor for coronary artery disease (CAD), guidelines for management of CAD and CKD are limited, partially due to historical exclusion of these patients from randomized controlled trials (RCTs). The 2021 American College of Cardiology (ACC)/American Heart Association (AHA)/Society for Cardiovascular Angiography and Interventions (SCAI) Guidelines for Coronary Artery Revascularization1 recommend coronary revascularization in patients presenting with CKD and ST-elevated myocardial infarction (STEMI), along with measures to reduce the risk of contrast-induced acute kidney injury (AKI) (Class I Recommendation with Level C-Limited Data Quality of Evidence/Expert Opinion).

Transcatheter edge-to-edge repair (TEER) has emerged to address symptomatic atrial functional mitral regurgitation (aFMR) in patients who are at high ...

Hypertrophic cardiomyopathy is a common cause of non-ischaemic sudden cardiac death (SCD). Left ventricular hypertrophy (LVH) without cardiomyopathy-r...